Literature DB >> 14531924

Malignancies in sickle cell disease patients treated with hydroxyurea.

Alina Ferster, Eric Sariban, Nathalie Meuleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14531924     DOI： 10.1046/j.1365-2141.2003.04614.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient.

Authors:  Samuel Regan; Xuebin Yang; Niklas K Finnberg; Wafik S El-Deiry; Jeffrey J Pu
Journal:  Cancer Biol Ther       Date:  2019-08-18       Impact factor: 4.742

2.  Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.

Authors:  James G Taylor; Deepika S Darbari; Deepika S Darari; Irina Maric; Zachariah McIver; Diane C Arthur
Journal:  Ann Intern Med       Date:  2011-11-15       Impact factor: 25.391

Review 3.  Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Authors:  Sophie Lanzkron; John J Strouse; Renee Wilson; Mary Catherine Beach; Carlton Haywood; HaeSong Park; Catherine Witkop; Eric B Bass; Jodi B Segal
Journal:  Ann Intern Med       Date:  2008-05-05       Impact factor: 25.391

4.  Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Authors:  Nancy A Omondi; Stacy E Stickney Ferguson; Navneet S Majhail; Ellen M Denzen; George R Buchanan; Ann E Haight; Richard J Labotka; J Douglas Rizzo; Elizabeth A Murphy
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.